Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial

Item
http://www.wikidata.org/entity/Q28540831
Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 TrialImpact of Schistosoma mansoni on malaria transmission in Sub-Saharan AfricaBuilding a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural povertyControlling schistosomiasis with praziquantel: How much longer without a viable alternative?Natural products with antischistosomal activity.Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis.Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.Something old, something new: is praziquantel enough for schistosomiasis control?Health & Demographic Surveillance System Profile: The Taabo Health and Demographic Surveillance System, Côte d'Ivoire.Interactions between mefloquine and the anti-fibrotic drug silymarin on Schistosoma mansoni infections in mice.Antischistosomal agents: state of art and perspectives.Schistosomiasis therapeutics: whats in the pipeline?Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.Prevalence and intensity of Schistosoma haematobium infection among schoolchildren in central Zambia before and after mass treatment with a single dose of praziquantel.Challenges and recent progress in drug discovery for tropical diseases
P2860

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial

Item
http://www.wikidata.org/entity/Q28540831
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@ast
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@en
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@nl
type
label
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@ast
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@en
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@nl
prefLabel
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@ast
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@en
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Praziquantel, mefloquine-prazi ...... exploratory, open-label trial
@en
P2093
P2860
P304
P31
P3181
P356
10.1371/JOURNAL.PNTD.0002975
P407
P433
P478
P50
P577
P5875
P698
P921
P932